Endotoxin in parenteral medicines may be a risk factor in severe sepsis

被引：0
|
作者：
Szathmary, S
Hegyi, E
Grandics, P
机构：
[1] Clarigen Inc, Carlsbad, CA 92008 USA
[2] Univ Calif Davis, Dept Pathol, Med Ctr, Sacramento, CA 95816 USA
来源：
PDA JOURNAL OF PHARMACEUTICAL SCIENCE AND TECHNOLOGY | 2005年 / 59卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
引用
收藏
页码：240 / 245
页数：6
相关论文
共 50 条
  • [1] Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis
    Boldt, J
    LANCET, 2001, 358 (9281): : 581 - 582
  • [2] Sepsis may be a new risk factor for invasive aspergillosis in immunocompetent patients
    Tartiere, D.
    Seguin, P.
    Malledant, Y.
    Gangneux, J. P.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (08) : 1135 - 1136
  • [3] Outpatient Parenteral Antimicrobial Therapy and Severe Sepsis Mortality
    Dailey, Michael P.
    CLINICAL INFECTIOUS DISEASES, 2024,
  • [4] Use of an endotoxin adsorber in the treatment of severe abdominal sepsis
    Kulabukhov, V. V.
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2008, 52 (07) : 1024 - 1025
  • [5] Endotoxin adsortion as adjuvant therapy in gramnegative severe sepsis
    Candel, F. J.
    Martinez-Sagasti, F.
    Borges M, M.
    Maseda, E.
    Herrera-Gutierrez, M.
    Garnacho-Montero, J.
    Maynar, F. J.
    Zaragoza, R.
    Mensa, J.
    Azanza, J. R.
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2010, 23 (03) : 115 - 121
  • [6] Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis - Reply
    Schortgen, F
    Brochard, L
    LANCET, 2001, 358 (9281): : 582 - 582
  • [7] Newly developed endotoxin measurement method (endotoxin activity assay) may reflect the severity of sepsis
    H Murayama
    Y Kakihana
    T Oryoji
    N Kiyonaga
    S Tashiro
    T Imabayashi
    T Yasuda
    Y Kanmura
    Critical Care, 13 (Suppl 1):
  • [8] Renal recovery during endotoxin adsorption in patients with severe sepsis
    Zimmermann, M
    Staubach, KH
    Boehme, M
    Wischnewsky, MB
    Reinhart, K
    SHOCK, 2004, 21 : 129 - 129
  • [9] The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis
    Opal, Steven M.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2007, 297 (05) : 365 - 377
  • [10] Asthma may not be a risk factor for severe COVID-19 in children
    Amat, Flore
    Delaisi, Bertrand
    Labbe, Jean-Philippe
    Leonardi, Jacques
    Houdouin, Veronique
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (06): : 2478 - 2479
12345